title: Granulocyte colony-stimulating factor and erythropoietin for the anemia of myelodysplastic syndromes: a real improvement with respect to erythropoietin alone?
authors.forename: P
authors.initials: P
authors.lastname: Musto
authors.forename: A
authors.initials: A
authors.lastname: Falcone
authors.forename: M
authors.initials: M
authors.lastname: Carotenuto
authors.forename: L
authors.initials: L
authors.lastname: Catalano
authors.forename: A
authors.initials: A
authors.lastname: Cennamo
authors.forename: B
authors.initials: B
authors.lastname: Rotoli
mesh_terms: D000753:Anemia, Refractory / Q000628:therapy*; D000756:Anemia, Sideroblastic / Q000628:therapy*; D001803:Blood Transfusion; D004359:Drug Therapy, Combination; D004921:Erythropoietin / Q000627:therapeutic use*; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use*; D006454:Hemoglobins / Q000378:metabolism; D006801:Humans; D007958:Leukocyte Count; D009190:Myelodysplastic Syndromes / Q000097:blood / Q000628:therapy*
chemical_list: D006454:Hemoglobins; D004921:Erythropoietin; D016179:Granulocyte Colony-Stimulating Factor